Innovus Pharmaceuticals Closes Acquisition of All of Beyond Human, LLCs Products Life Science Investing
Intellipharmaceutics Continues to Reposition as Specialty Drug Delivery Company Life Science Investing
Zynerba Pharmaceuticals Reports ZYN002 Granted Orphan Drug Designation for Fragile X Syndrome Life Science Investing
Dendritic Cell Vaccine Inhibits Tumor Progression in Preclinical Liver Cancer Model Biotech Investing
DelMar Pharmaceuticals Conference Call – CEO Jeffrey Bacha on Q2 2016 Results Life Science Investing
Retrophin Receives European Orphan Drug Designation for RE-024 for the Treatment of Pantothenate Kinase-Associated Neurodegeneration Biotech Investing
